352 related articles for article (PubMed ID: 8213632)
1. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification.
Schwonzen M; Pohl C; Steinmetz T; Seckler W; Vetten B; Thiele J; Wickramanayake D; Diehl V
Br J Haematol; 1993 Feb; 83(2):232-9. PubMed ID: 8457472
[TBL] [Abstract][Full Text] [Related]
3. CD43 expression in B cell lymphoma.
Treasure J; Lane A; Jones DB; Wright DH
J Clin Pathol; 1992 Nov; 45(11):1018-22. PubMed ID: 1280654
[TBL] [Abstract][Full Text] [Related]
4. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
[TBL] [Abstract][Full Text] [Related]
5. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and subclassification of follicle center and mantle cell lymphomas on fine-needle aspirates: A cytologic and immunocytochemical approach based on the Revised European-American Lymphoma (REAL) classification.
Rassidakis GZ; Tani E; Svedmyr E; Porwit A; Skoog L
Cancer; 1999 Aug; 87(4):216-23. PubMed ID: 10455210
[TBL] [Abstract][Full Text] [Related]
7. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
8. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
9. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
10. B-cell chronic lymphocytic leukaemia stage 0. An immunophenotypic study of 66 cases and comparison with B small cell lymphomas.
Stramignoni A; Valente G; Geuna M; Stramignoni D; Novero D; Ragona R; Resegotti L; Palestro G
Eur J Haematol; 1994 Mar; 52(3):145-51. PubMed ID: 8168593
[TBL] [Abstract][Full Text] [Related]
11. Monocytoid B cells. A comparative clinical pathological study of their distribution in different types of low-grade lymphomas.
Mollejo M; Menárguez J; Cristóbal E; Algara P; Sánchez-Díaz E; Fraga M; Piris MA
Am J Surg Pathol; 1994 Nov; 18(11):1131-9. PubMed ID: 7943534
[TBL] [Abstract][Full Text] [Related]
12. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
13. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour.
Wenzel C; Dieckmann K; Fiebiger W; Mannhalter C; Chott A; Raderer M
Leuk Lymphoma; 2001 Aug; 42(4):823-9. PubMed ID: 11697516
[TBL] [Abstract][Full Text] [Related]
14. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
[TBL] [Abstract][Full Text] [Related]
16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
18. B-cell lymphomas with coexpression of CD5 and CD10.
Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
de Leon ED; Alkan S; Huang JC; Hsi ED
Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
[TBL] [Abstract][Full Text] [Related]
20. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease.
Sundeen JT; Longo DL; Jaffe ES
Am J Surg Pathol; 1992 Feb; 16(2):130-7. PubMed ID: 1370753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
